Recurrent Middle Ear Cancer: Case Report
Journal Title: Diseases & Research - Year 2024, Vol 4, Issue 1
Abstract
Background: Middle ear cancer is clinically uncommon, representing approximately 1.5% of ear malignancies and 0.03% to 0.06% of all cancers. Recurrent cases of middle ear cancer are particularly rare. This report discusses a patient with middle ear cancer who experienced invasive growth into surrounding tissues and developed a large cancerous ulcer post-resection. Case Summary: A 72-year-old male underwent a subtotal resection of the right temporal bone in February 2021, diagnosed with squamous cell carcinoma of the middle ear. Regrettably, he did not receive follow-up medical care after surgery. In June 2022, he returned to the hospital with complaints of pus and bleeding from a mass behind his ear. Further examinations led to a diagnosis of recurrent middle ear cancer with extensive local infiltration. We initiated a combination treatment comprising targeted therapy, chemotherapy, radiotherapy, and local application of rhGM-CSF. The patient showed remarkable sensitivity to this treatment plan, evidenced by a significant reduction in the mass and discharge behind the ear within a week. After two cycles of combined targeted therapy and chemotherapy, the treatment's effectiveness was assessed as PR (partial response) via magnetic resonance imaging. As of August 2023, the patient remains in stable condition. Conclusion: For such a recurrent middle ear cancer with giant cancerous ulcer, we suggest do not neglect local treatment while giving anti-tumor treatment.
Authors and Affiliations
Hui Ma, Hongxun Ye, Fei Gao
Keywords
Related Articles
- EP ID EP740222
- DOI 10.54457/DR.202401001
- Views 31
- Downloads 1
Research Advance in GP73 in the Clinical Diagnosis and Treatment of Patients with Chronic Hepatitis B
Golgi protein 73 (GP73) is a type II integrative membrane protein located in the cellular Golgi apparatus. Research shows, that in addition to protein processing, GP73 is involved in cell differentiation, intercellular s...
Oral Versus Intravenous Chemotherapy in COVID-19 Epidemic
The novel coronavirus has a significant impact on the routine clinical practice for cancer patients in China since De-cember 2019. During the epidemic in mainland China, especially Wuhan, the intravenous chemotherapies o...
A Commentary on the Natural Disease Progression Sequence of Chronic Hepatitis B
Hepatitis B virus (HBV), an ancient family of hepatotropic DNA viruses with origins dating back millions of years, remains a major burden to human health today, although hepatitis B vaccines have dramatically reduced the...
Plasma Exchange to Treat Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome after Anti-CD19 Chimeric Antigen Receptor-T Cell Infusion: A Case Report
Adoptive cell immunotherapy with chimeric antigen receptor-T (CAR-T) cells has shown remarkable clinical out-comes. However, cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICA...
Multiparameter Flow Cytometry: An Important Auxiliary Tool for The Diagnosis and Differential Diagnosis of Myelodysplastic Neoplasms
Multiparameter flow cytometry (MFC) shows promise in the diagnosis and differential diagnosis of myelodysplastic neoplasms (MDS). By identifying abnormal immunophenotypes of different cell lineages in bone marrow (BM) ce...